SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-055357
Filing Date
2019-11-05
Accepted
2019-11-05 19:41:53
Documents
2
Period of Report
2019-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2246
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4064
  Complete submission text file 0001209191-19-055357.txt   7691
Mailing Address C/O NEKTAR THERAPEUTIC 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address
BANSAL AJAY (Reporting) CIK: 0001236922 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38667 | Film No.: 191194773

Mailing Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617
Business Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Issuer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations